The bisphosphonates alendronate and zoledronate induce adaptations of aerobic metabolism in permanent human endothelial cells
Open Access
- 27 September 2023
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-12
Abstract
Nitrogen-containing bisphosphonates (NBPs), compounds that are widely used in the treatment of bone disorders, may cause side effects related to endothelial dysfunction. The aim of our study was to investigate the effects of chronic 6-day exposure to two common bone-preserving drugs, alendronate and zoledronate, on endothelial function and oxidative metabolism of cultured human endothelial cells (EA.hy926). NBPs reduced cell viability, induced oxidative stress and a pro-inflammatory state and downregulated the prenylation-dependent ERK1/2 signaling pathway in endothelial cells. In addition, NBPs induced increased anaerobic respiration and slightly increased oxidative mitochondrial capacity, affecting mitochondrial turnover through reduced mitochondrial fission. Moreover, by blocking the mevalonate pathway, NBPs caused a significant decrease in the level of coenzyme Q10, thereby depriving endothelial cells of an important antioxidant and mitochondrial electron carrier. This resulted in increased formation of reactive oxygen species (ROS), upregulation of antioxidant enzymes, and impairment of mitochondrial respiratory function. A general decrease in mitochondrial respiration occurred with stronger reducing fuels (pyruvate and glutamate) in NBP-treated intact endothelial cells, and significantly reduced phosphorylating respiration was observed during the oxidation of succinate and especially malate in NBP-treated permeabilized endothelial cells. The observed changes in oxidative metabolism caused a decrease in ATP levels and an increase in oxygen levels in NBP-treated cells. Thus, NBPs modulate the energy metabolism of endothelial cells, leading to alterations in the cellular energy state, coenzyme Q10 redox balance, mitochondrial respiratory function, and mitochondrial turnover.Keywords
Funding Information
- National Science Centre, Poland (OPUS 2020/37/B/NZ1/01188)
This publication has 42 references indexed in Scilit:
- The influence of high glucose on the aerobic metabolism of endothelial EA.hy926 cellsPflügers Archiv - European Journal of Physiology, 2012
- Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viabilityBone, 2011
- Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitroOral Diseases, 2010
- Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis managementDrug, Healthcare and Patient Safety, 2010
- Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitroClinical Oral Investigations, 2009
- Uncoupling protein 1 inhibition by purine nucleotides is under the control of the endogenous ubiquinone redox stateBiochemical Journal, 2009
- Endothelial-Dependent Mechanisms of Leukocyte Recruitment to the Vascular WallCirculation Research, 2007
- ERK is an anti-inflammatory signal that suppresses expression of NF-κB-dependent inflammatory genes by inhibiting IKK activity in endothelial cellsCellular Signalling, 2006
- Safety Profiles for the HMG-CoA Reductase InhibitorsDrugs, 2001
- Regulation of the mevalonate pathwayNature, 1990